Cystoscopic application of <scp>RADA16</scp> peptide for refractory haematuria from radiation cystitis
Cystoscopic application of RADA16 shows promise for treating intractable haematuria from radiation cystitis. It is the first treatment option that potentially provides both haemostasis as well as promoting bladder healing and regression of radiation-induced telangiectasia.
Authors
- Jonathan Kam (ORCID: https://orcid.org/0000-0001-6354-9664)
- Muhammad Shamim Khan (ORCID: https://orcid.org/0000-0002-1861-0830)
- Yasmin Abu‐Ghanem (ORCID: https://orcid.org/0000-0003-3682-5963)
- Youssef Ibrahim (ORCID: https://orcid.org/0000-0003-0931-9707)
- Rajesh Nair (ORCID: https://orcid.org/0000-0003-1760-9608)
- Elsie Mensah (ORCID: https://orcid.org/0000-0003-1688-9767)
- Francesco Del Giudice (ORCID: https://orcid.org/0000-0003-3865-5988)
- Ramesh Thurairaja
Institutions
- The University of Sydney (AU)
- Guy's Hospital (GB)
- Nepean Hospital (AU)
- Cleveland Clinic London (GB)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1111/bju.70075
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00